• Issue

    European Journal of Haematology: Volume 96, Issue 1

    1-106
    January 2016
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Issue Information

Free Access

Table of Contents

  • Page: 1
  • First Published: 22 December 2015
Free Access

Editorial Board

  • Page: 2
  • First Published: 22 December 2015

Editorials

When is a nodule more than a nodule?

Kyle R. Brownback, 
  • Pages: 3-4
  • First Published: 15 April 2015

Risk of thrombosis in patients with myeloproliferative neoplasms and elevated platelet counts

Anders Wahlin, 
  • Pages: 5-6
  • First Published: 13 May 2015

GvHD prophylaxis in non-haploidentical allogeneic peripheral blood stem cell transplantation: beyond the standard to prevent relapse in patients with high-risk chronic lymphoproliferative diseases?

Francesco Onida, 
  • Pages: 7-8
  • First Published: 22 December 2015

Review Article

Free Access

Advances in first-line treatment of chronic lymphocytic leukemia: current recommendations on management and first-line treatment by the German CLL Study Group (GCLLSG)

Paula Cramer,  Petra Langerbeins,  Barbara Eichhorst,  Michael Hallek, 
  • Pages: 9-18
  • First Published: 02 September 2015

Original Articles

Utility of labile plasma iron and transferrin saturation in addition to serum ferritin as iron overload markers in different underlying anemias before and after deferasirox treatment

John B. Porter,  Mohsen El-Alfy,  Vip Viprakasit,  Stephane Giraudier,  Lee Lee Chan,  Yongrong Lai,  Ali El-Ali,  Jackie Han,  Maria D. Cappellini, 
  • Pages: 19-26
  • First Published: 18 February 2015

OCTET-CY: a phase II study to investigate the efficacy of post-transplant cyclophosphamide as sole graft-versus-host prophylaxis after allogeneic peripheral blood stem cell transplantation

Udo Holtick,  Jens-Markus Chemnitz,  Alexander Shimabukuro-Vornhagen,  Sebastian Theurich,  Geothy Chakupurakal,  Anke Krause,  Anne Fiedler,  Leo Luznik,  Martin Hellmich,  Dominik Wolf,  Michael Hallek,  Michael von Bergwelt-Baildon,  Christof Scheid, 
  • Pages: 27-35
  • First Published: 23 February 2015

Prospective validation of predictive value of abdominal computed tomography scan on time to first treatment in Rai 0 chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study

Massimo Gentile,  Giovanna Cutrona,  Stefano Molica,  Fiorella Ilariucci,  Francesca R. Mauro,  Nicola Di Renzo,  Francesco Di Raimondo,  Iolanda Vincelli,  Katia Todoerti,  Serena Matis,  Caterina Musolino,  Sonia Fabris,  Marta Lionetti,  Luciano Levato,  Simona Zupo,  Francesco Angrilli,  Ugo Consoli,  Gianluca Festini,  Giuseppe Longo,  Agostino Cortelezzi,  Pellegrino Musto,  Massimo Federico,  Antonino Neri,  Manlio Ferrarini,  Fortunato Morabito, 
  • Pages: 36-45
  • First Published: 09 March 2015

Proteasome inhibitors and IMiDs can overcome some high-risk cytogenetics in multiple myeloma but not gain 1q21

Hareth Nahi,  Thea Kristin Våtsveen,  Johan Lund,  Bart M.S. Heeg,  Birgitte Preiss,  Evren Alici,  Michael Boe Møller,  Karin Fahl Wader,  Hanne E.H. Møller,  Lill Anny Grøseth,  Brian Østergaard,  Hong Yan Dai,  Erik Holmberg,  Gösta Gahrton,  Anders Waage,  Niels Abildgaard, 
  • Pages: 46-54
  • First Published: 16 March 2015

Outcome of acute myeloid leukemia patients with pulmonary nodules of uncertain etiology receiving allogeneic hematopoietic progenitor cell transplant

Sara J. Lim,  Matthew J. Lim,  Anastasios Raptis,  Jing-Zhou Hou,  Rafic Farah,  Stanley Marks,  Annie Im,  Kathleen Dorritie,  Alison Sehgal,  Mounzer Agha,  Seah H. Lim, 
  • Pages: 55-59
  • First Published: 17 March 2015

Importance of pharmacokinetic studies in the management of acquired factor X deficiency

Ming Y. Lim,  Timothy McCarthy,  Sheh-Li Chen,  Marian A. Rollins-Raval,  Alice D. Ma, 
  • Pages: 60-64
  • First Published: 17 March 2015

Chronic myelomonocytic leukemia with nucleophosmin (NPM1) mutation

Jie Peng,  Zhuang Zuo,  Bin Fu,  Yasuhiro Oki,  Guilin Tang,  Maitrayee Goswami,  Priyanka Priyanka,  Tariq Muzzafar,  L. Jeffrey Medeiros,  Rajyalakshmi Luthra,  Sa A. Wang, 
  • Pages: 65-71
  • First Published: 24 March 2015

Unavailability of thymidine kinase does not preclude the use of German comprehensive prognostic index: results of an external validation analysis in early chronic lymphocytic leukemia and comparison with MD Anderson Cancer Center model

Stefano Molica,  Diana Giannarelli,  Rosanna Mirabelli,  Luciano Levato,  Antonio Russo,  Maria Linardi,  Massimo Gentile,  Fortunato Morabito, 
  • Pages: 72-77
  • First Published: 27 March 2015

Cytomegalovirus reactivation in patients with multiple myeloma

Tetsuo Hasegawa,  Yoshinobu Aisa,  Kengo Shimazaki,  Chisako Ito,  Tomonori Nakazato, 
  • Pages: 78-82
  • First Published: 21 March 2015

Masked polycythaemia vera: presenting features, response to treatment and clinical outcomes

Alberto Alvarez-Larrán,  Anna Angona,  Agueda Ancochea,  Francesc García-Pallarols,  Concepción Fernández,  Raquel Longarón,  Beatriz Bellosillo,  Carlos Besses, 
  • Pages: 83-89
  • First Published: 21 March 2015

Thiotepa-based versus total body irradiation-based myeloablative conditioning prior to allogeneic stem cell transplantation for acute myeloid leukaemia in first complete remission: a retrospective analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Sandra Eder,  Myriam Labopin,  William Arcese,  Reuven Or,  Ignazio Majolino,  Andrea Bacigalupo,  Gennaro de Rosa,  Liisa Volin,  Dietrich Beelen,  Hendrik Veelken,  Nicolaas P. M. Schaap,  Jurgen Kuball,  Jan Cornelissen,  Arnon Nagler,  Mohamad Mohty, on behalf of the Acute Leukemia Working Party , 
  • Pages: 90-97
  • First Published: 21 March 2015
Open Access

Thrombosis in thrombocythemic Ph- myeloproliferations is associated with higher platelet count prior to the event: results of analyses of prothrombotic risk factors from a registry of patients treated with anagrelide

Jiří Schwarz,  Petra Ovesná,  Olga Černá,  Jarmila Kissová,  Jacqueline Maaloufová Soukupová,  Yvona Brychtová,  Michael Doubek,  Libor Červinek,  Eduard Cmunt,  Petr Dulíček,  Vít Campr,  Leoš Křen,  Miroslav Penka,  for CZEMP – Czech Group for Ph- Myeloproliferative Disorders , 
  • Pages: 98-106
  • First Published: 25 March 2015